Home  Contact Us
  Follow Us On:
 
Search:
Advertising Advertising Free Newsletter Free E-Newsletter
NEWS

New Sinopharm COVID-19 vaccine approved for clinical trials
Published on: 2021-04-12
Share to
User Rating: / 0
PoorBest 

A new COVID-19 vaccine developed by China's Sinopharm has recently been approved for clinical trials.
 

The new recombinant COVID-19 vaccine, developed by the National Vaccine & Serum Institute, a R&D center of Sinopharm's bioscience subsidiary the China National Biotec Group (CNBG), got approval from the National Medical Products Administration on Friday, the CNBG said on its official Weibo account on Saturday.
 

The vaccine is based on the structural features of the receptor binding domain (RBD) on the virus' spike protein (S-protein). It uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralizing antibodies.
 

The company said that recombinant vaccine technology is mature and suitable for large-scale production. The production does not require facilities with high biosafety levels since the process does not involve live viruses.
 

The recombinant vaccine is the company's third COVID-19 vaccine. Last December, an inactivated vaccine developed by the Beijing Biological Products Institute Co., Ltd. under CNBG became the first Chinese COVID-19 vaccine to have conditional marketing authorization.
 

In February, another inactivated vaccine from the Wuhan Institute of Biological Products, a CNBG affiliate, was allowed to enter the market on a conditional basis.
 

More than 161.12 million doses of COVID-19 vaccines have been administered across China as of Friday, the National Health Commission said Saturday.
 

又一款国产新冠疫苗获批临床试验

4月10日晚消息,国药集团中国生物研究院重组新冠病毒疫苗于4月9日获得国家药品监督管理局临床试验批件。这是继国药集团中国生物两款新冠灭活疫苗后,又一技术路线的新冠疫苗获批临床,成为中国生物第三款新冠疫苗。
 

此前,中国生物北京生物制品研究所、武汉生物制品研究所两款新冠灭活疫苗已分别于2020年12月30日、2021年2月25日在国内获批附条件上市。

Comments (0)Add Comment

Write comment

security code
Write the displayed characters


busy
    Subscription    |     Advertising    |     Contact Us    |
Address: Magnetic Plaza, Building A4, 6th Floor, Binshui Xi Dao.
Nankai District. 300381 TIANJIN. PR CHINA
Tel: +86 22 23917700
E-mail: webmaster@businesstianjin.com
Copyright 2021 BusinessTianjin.com. All rights reserved.